Dr. Roxana Fuiorea

Competente:

  • Dermatovenerologie – diagnosticul si tramatmentul de specialitate al afectiunilor cutanate si bolilor cu transmitere sexuala
  • Dermatoscopie – diagnosticul si supravegherea dermatoscopica a leziunilor de la nivelul pielii.
  • Chirurgie dermatologica
  • Dermatologie pediatrica
  • Dermato-cosmetologie

Cursuri postuniversitare:

  • Curs de Abordari Terapeutice in Simptomatologia Bolii Venoase Cronice - Universitatea de Medicina si Farmacie „Carol Davila” Bucuresti 2020
  • Curs Actualitati in Dermatoscopie – Metoda de Diagnostic in melanomul incipient, - Societatea Romana de Dermato-Oncologie, Cluj Napoca, 2019
  • Curs Dermatofocus in Psoriazis - Universitatea de Medicina si Farmacie Grigore T. Popa, Iasi / Asociatia Dermatologilor din Moldova., 2019
  • Curs Dermatoscopie practica, Spitalul Clinic Judetean de Urgenta, Craiova, 2018
  • Curs de Formare Continua „Curs de dermato-estetica” - Universitatea de Medicina si Farmacie „Grigore T. Popa”, Iasi, Colegiul Medicilor Iasi., 2014
  • Curs de Formare Continua „Curs de dermato-pedriatrie” - Universitatea de Medicina si Farmacie „Grigore T. Popa”, Iasi, Colegiul Medicilor Iasi., 2014
  • Curs de Formare Continua „Scoala Dermatologica – Primavara Dermatologica Ieseana 2014” - Universitatea de Medicina si Farmacie „Grigore T. Popa”, Iasi, Colegiul Medicilor Iasi, 2014

Participari la Conferinte/Congrese nationale cu participare internationala: 15

Participare la studii clinice: 

  • 2013-2018 - Multicenter Randomized, Double Blind, Placebo-Controlled Study comparing the efficacy and safety of LY2439821 to Etanercept and placebo in Patients with moderate-to-severe Plaque Psoriasis.  Elly Lilly // Spitalul Clinic Judetean de urgenta Craiova 
  • 2015-2017 - Multi Center, Randomized, Double Blind, Parallel-GroupVehicle Controlled Study to Compare the efficacy and safety of CD5789 50ug/g Creamversus vehicle Cream in subjects with Acne Vulgaris. Chiltern International // Spitalul Clinic Judetean de Urgenta, Craiova
  • 2014 – 2015 - Phase III 2 arms, multicenter, randomised, double blind study to assess the eficacy and safety of Ozenoxacin 1% cream applied twice daily for 5 days versus placebo in the treatment of patients with Impedigo.   Chiltern International // Spitalul Clinic Judetean de Urgenta, Craiova
  • 2013 – 2015 - Phase 3, Multicenter, Randomized, Double Blind, Active Controlled Study to evaluate the efficacy and safety of IV and oral Delafloxacin compared with Vancomycin + Aztreonam in patients with acute bacterial skin and skin structure infections.   Melinta Therapeutics // Spitalul Clinic Judetean de Urgenta, Craiova

Membru in :

  • Societatea Romana de Dermatologie